Evidence-Based Medicine Electronic Decision Support Study (EBMeDS)

This study has been completed.
Sponsor:
Collaborators:
The Finnish Medical Society Duodecim
National Institute for Health and Welfare, Finland
Duodecim Medical Publications Ltd.
ProWellness Ltd.
The Finnish Funding Agency for Technology and Innovation (TEKES)
Information provided by (Responsible Party):
Tiina Kortteisto, University of Tampere
ClinicalTrials.gov Identifier:
NCT00915304
First received: June 5, 2009
Last updated: December 17, 2012
Last verified: December 2012
  Purpose

The purpose of this study is to analyze the effect of the Evidence-Based Medicine electronic Decision Support (EBMeDS) automatic reminders in primary health care.

Hypothesis (1)is that in the intervention group the total number of EBMeDS reminders will decrease compared to the control group.

Hypothesis (2) is that in the intervention group the quality measures will increase faster compared to the control group at follow-up time.


Condition Intervention Phase
Decision Support Systems, Clinical
Behavioral: The EBMeDS reminders
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Health Services Research
Official Title: Patient Specific Automatic Reminders in Primary Care - the EBMeDS Randomised Trial

Further study details as provided by University of Tampere:

Primary Outcome Measures:
  • The number of reminders triggered (in relation to the number of eligible patients, Ri/Ni) during repeated Virtual Health Checks (VHCs) [ Time Frame: Follow-up time max one and half year ] [ Designated as safety issue: Yes ]
    VHC will be performed once a week for the whole study population, beginning at baseline and before randomisation. The main outcome measure is Ri/Ni at follow-up time after commencement of the study where Ri is the total number of reminders triggered by the patient record data in intervention and in control group at the time of analysis, and Ni is the total number of patients.


Secondary Outcome Measures:
  • Specific clinical measures compared to an intervention and a control group [ Designated as safety issue: Yes ]
    Clinical measures as mean values of laboratory parameters, for example a mean level of HbA1c, a mean level of total cholesterol.


Enrollment: 12101
Study Start Date: June 2009
Study Completion Date: February 2011
Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: The EBMeDS reminders

    Phase I: EBMeDS reminders specific to the visiting or caring patient and his/her clinical problem are generated when the practitioner uses the electronic patient record. During visits of intervention group patients the EBMeDS reminders will be shown on screen to the practitioner.

    Phase II: As phase I and in addition, results of the Virtual Health Check (VHC) of all the intervention group patients will be shown to the practitioners.Phase II will be fulfilled in Autumn 2010 and follow-up time will be about 3 months.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All residents of Sipoo who have patient ID number in the Mediatri electronic patient record system in Sipoo Health Centre

Exclusion Criteria:

  • Those residents who's occupational health care is produced by Sipoo Health Centre
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00915304

Locations
Finland
University of Tampere; School of Health Sciences
Tampere, Finland, 33014
Sponsors and Collaborators
University of Tampere
The Finnish Medical Society Duodecim
National Institute for Health and Welfare, Finland
Duodecim Medical Publications Ltd.
ProWellness Ltd.
The Finnish Funding Agency for Technology and Innovation (TEKES)
Investigators
Study Director: Pekka Rissanen, Professor University of Tampere; School of Health Sciences
Principal Investigator: Tiina Kortteisto, MSc University of Tampere; School of Health Sciences
  More Information

Additional Information:
No publications provided by University of Tampere

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Tiina Kortteisto, researcher, University of Tampere
ClinicalTrials.gov Identifier: NCT00915304     History of Changes
Other Study ID Numbers: EBMeDS-40344-06
Study First Received: June 5, 2009
Last Updated: December 17, 2012
Health Authority: Finland: Ethics Committee

Keywords provided by University of Tampere:
Clinical Decision Support System
Automatic reminder
Primary care
Evidence-Based Medicine

ClinicalTrials.gov processed this record on April 17, 2014